JP4739521B2 - Ｎ−末端コリン結合プロテインａ切端形のアミノ酸を含むポリペプチド、それに由来するワクチンおよびその使用 - Google Patents

Ｎ−末端コリン結合プロテインａ切端形のアミノ酸を含むポリペプチド、それに由来するワクチンおよびその使用 Download PDF

Info

Publication number
JP4739521B2
JP4739521B2 JP2000541960A JP2000541960A JP4739521B2 JP 4739521 B2 JP4739521 B2 JP 4739521B2 JP 2000541960 A JP2000541960 A JP 2000541960A JP 2000541960 A JP2000541960 A JP 2000541960A JP 4739521 B2 JP4739521 B2 JP 4739521B2
Authority
JP
Japan
Prior art keywords
polypeptide
amino acid
acid sequence
choline
cbpa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000541960A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002516662A5 (enExample
JP2002516662A (ja
Inventor
エレイン アイ テュオマネン
エイチ ロバート マーシュア
テレサ エム ワイズマン
レスリー シドナー ジョンソン
スコット ケーニグ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Jude Childrens Research Hospital
Original Assignee
St Jude Childrens Research Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/056,019 external-priority patent/US6858706B2/en
Application filed by St Jude Childrens Research Hospital filed Critical St Jude Childrens Research Hospital
Publication of JP2002516662A publication Critical patent/JP2002516662A/ja
Publication of JP2002516662A5 publication Critical patent/JP2002516662A5/ja
Application granted granted Critical
Publication of JP4739521B2 publication Critical patent/JP4739521B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2000541960A 1998-04-07 1999-04-07 Ｎ−末端コリン結合プロテインａ切端形のアミノ酸を含むポリペプチド、それに由来するワクチンおよびその使用 Expired - Fee Related JP4739521B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8087898P 1998-04-07 1998-04-07
US09/056,019 US6858706B2 (en) 1998-04-07 1998-04-07 Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
US60/080,878 1998-04-07
US09/056,019 1998-04-07
PCT/US1999/007669 WO1999051188A2 (en) 1998-04-07 1999-04-07 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof

Publications (3)

Publication Number Publication Date
JP2002516662A JP2002516662A (ja) 2002-06-11
JP2002516662A5 JP2002516662A5 (enExample) 2006-06-01
JP4739521B2 true JP4739521B2 (ja) 2011-08-03

Family

ID=26734874

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000541960A Expired - Fee Related JP4739521B2 (ja) 1998-04-07 1999-04-07 Ｎ−末端コリン結合プロテインａ切端形のアミノ酸を含むポリペプチド、それに由来するワクチンおよびその使用

Country Status (14)

Country Link
JP (1) JP4739521B2 (enExample)
KR (1) KR100638503B1 (enExample)
CN (1) CN1191851C (enExample)
AU (2) AU3479699A (enExample)
BR (1) BR9909910A (enExample)
CA (1) CA2326388C (enExample)
HU (1) HUP0102306A3 (enExample)
IL (1) IL138939A0 (enExample)
MX (1) MXPA00009899A (enExample)
NO (1) NO20005081L (enExample)
NZ (1) NZ507983A (enExample)
PL (1) PL193132B1 (enExample)
TR (1) TR200003498T2 (enExample)
WO (1) WO1999051188A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
CA2808919C (en) 2005-12-22 2016-04-19 Glaxosmithkline Biologicals S.A. Streptococcus pneumoniae capsular saccharide vaccine
KR101579947B1 (ko) 2007-06-26 2015-12-28 글락소스미스클라인 바이오로지칼즈 에스.에이. 스트렙토코쿠스 뉴모니애 캡슐 다당류 컨쥬게이트를 포함하는 백신
WO2009127676A1 (en) 2008-04-16 2009-10-22 Glaxosmithkline Biologicals S.A. Vaccine
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
AU2012257771C1 (en) 2011-05-17 2015-12-03 Glaxosmithkline Biologicals S.A. Vaccine against Streptococcus pneumoniae
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592876B1 (en) * 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
WO1997041151A2 (en) * 1996-05-01 1997-11-06 The Rockefeller University Choline binding proteins for anti-pneumococcal vaccines
DE69739981D1 (de) * 1996-10-31 2010-10-14 Human Genome Sciences Inc Streptococcus pneumoniae-Antigene und Impfstoffe
AU5355398A (en) * 1996-11-12 1998-06-03 Regents Of The University Of Minnesota C3 binding protein of (streptococcus pneumoniae)
US6858706B2 (en) * 1998-04-07 2005-02-22 St. Jude Children's Research Hospital Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
DE69942176D1 (de) * 1998-04-07 2010-05-06 Medimmune Llc Choline-bindende proteine derivate aus pneumokoken als impfstoff

Also Published As

Publication number Publication date
AU3479699A (en) 1999-10-25
NZ507983A (en) 2004-03-26
KR100638503B1 (ko) 2006-10-26
BR9909910A (pt) 2002-01-15
WO1999051188A9 (en) 2000-10-12
HUP0102306A3 (en) 2008-04-28
CN1191851C (zh) 2005-03-09
CA2326388C (en) 2014-02-04
NO20005081D0 (no) 2000-10-09
CN1342088A (zh) 2002-03-27
PL193132B1 (pl) 2007-01-31
CA2326388A1 (en) 1999-10-14
AU3479799A (en) 1999-10-25
HUP0102306A1 (hu) 2001-09-28
NO20005081L (no) 2000-12-06
MXPA00009899A (es) 2002-05-08
PL347946A1 (en) 2002-04-22
IL138939A0 (en) 2001-11-25
TR200003498T2 (tr) 2001-10-22
AU764811B2 (en) 2003-08-28
KR20010052244A (ko) 2001-06-25
WO1999051188A3 (en) 2001-04-19
WO1999051188A2 (en) 1999-10-14
JP2002516662A (ja) 2002-06-11

Similar Documents

Publication Publication Date Title
US7128919B2 (en) Group B streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
US9181308B2 (en) Methods and compositions employing immunogenic fusion proteins
CA2253252A1 (en) Choline binding proteins for anti-pneumococcal vaccines
US9249199B2 (en) Synthetic Streptococcus pneumoniae vaccine
US6858706B2 (en) Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
US8529912B2 (en) Group B Streptococcus polypeptides, nucleic acids and therapeutic compositions and vaccines thereof
US6495139B2 (en) Identification and characterization of novel pneumococcal choline binding protein, CBPG, and diagnostic and therapeutic uses thereof
JP4739521B2 (ja) Ｎ−末端コリン結合プロテインａ切端形のアミノ酸を含むポリペプチド、それに由来するワクチンおよびその使用
WO2000029434A2 (en) PNEUMOCOCCAL CHOLINE BINDING PROTEINS, CbpG AND CbpD, DIAGNOSTIC AND THERAPEUTIC USES THEREOF
WO1999064610A1 (en) ZmpB, A NEW DETERMINANT OF VIRULENCE FOR STREPTOCOCCUS PNEUMONIAE, VACCINE DERIVED THEREFROM AND USES THEREOF
JPH10327882A (ja) 新規ＬｉｃＢ
CZ20003803A3 (cs) Izolovaný polypeptid, izolovaný analog polypeptidu, izolovaný imunogenní polypeptid, izolovaná nukleová kyselina, vektor, hostitelský vektorový systém, protilátka, farmaceutický prostředek, způsob vyvolání imunitní odpovědi, způsob zabránění infekce, vakcína a způsob léčení
JP2002506624A (ja) スタフィロコッカス・アウレウスｓｐｏ０ｊ２：ポリヌクレオチドおよび蛋白

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060407

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060407

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090420

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090721

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090729

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091020

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100121

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100520

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100702

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100702

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20100726

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100826

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101125

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110224

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110331

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110428

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140513

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees